Skip to main content

Building

A better future

through education, skill development and research

LEARN MORE

Does Inflammatory Bowel Disease Carry Certain Risks During Pregnancy?

Pregnant women with inflammatory bowel disease (IBD) are more likely to undergo delivery by Caesarean section and face certain risks during pregnancy, according to an analysis published in Alimentary Pharmacology & Therapeutics.

Wednesday, January 8, 2020 12:01 am EST

Pregnant women with inflammatory bowel disease (IBD) are more likely to undergo delivery by Caesarean section and face certain risks during pregnancy, according to an analysis of published studies.

The analysis, which is published in Alimentary Pharmacology & Therapeutics, found that one-third of all pregnancies in women with IBD were delivered by Caesarean section, reflecting almost a two-fold increase compared with women without IBD.

The analysis also demonstrated increased risks of gestational diabetes and preterm prelabour rupture of membranes in women with IBD. Placental-related disorders, such as pre-eclampsia, placental abruption, and placenta previa, did not appear to be increased in women with IBD.

Additional Information

Link to Study: https://onlinelibrary.wiley.com/doi/10.1111/apt.15587

About Journal 

Alimentary Pharmacology & Therapeutics is an international journal of gastroenterology and hepatology.

The journal accepts systematic reviews, meta-analyses, randomised controlled trials and original papers concerned with Gastroenterology and Hepatology.

AP&T is particularly interested in therapies and diagnostics, including all aspects of translation from bench to bedside: identification of novel therapeutic targets, epidemiology, clinical trials, drug safety and meta-analyses.

About Wiley

Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at www.wiley.com.

Multimedia Files:

Preview image

Contact:

Penny Smith +44 (0) 1243 770448 (UK)
newsroom@wiley.com

Business Wire NewsHQsm